06:57 EDT Idexx Laboratories (IDXX) jumps 7% to $573.99 after Q2 earnings beat, guidance raise
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Idexx Laboratories reports Q2 EPS $3.63, consensus $3.30
- Idexx Laboratories raises FY25 EPS view to $12.40-$12.77 from $11.93-$12.43
- IDXX Earnings this Week: How Will it Perform?
- Idexx Laboratories Hold Rating: Balancing Market Softness with Potential Product Growth
- Idexx Laboratories price target raised to $600 from $580 at Leerink